Recalls / Class II
Class IID-0169-2016
Product
PAPA+PGE1+PHENTO (30mg/20mcg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA
- Affected lot / code info
- 5 mL 06022015@11, exp 11/29/2015; 06082015@5, exp 12/5/2015; 06112015@7, exp 12/8/2015; 06112015@9, exp 12/8/2015; 06162015@7, exp 12/13/2015; 07092015@6, exp 1/5/2016; 07092015@7, exp 1/5/2016; 07162015@4, exp 1/12/2016; 07202015@1, exp 1/16/2016; 07202015@2, exp 1/16/2016; 08032015@6, exp 1/30/2016; 08142015@12, exp 2/10/2016; 08142015@13, exp 2/10/2016; 08142015@7, exp 2/10/2016; 08182015@14, exp 2/14/2016; 08242015@6, exp 2/20/2016 --- 10 mL 05042015@4, exp 10/31/2015; 06012015@6, exp 11/28/2015; 06022015@12, exp 11/29/2015; 06032015@5, exp 11/30/2015; 06082015@4, exp 12/5/2015; 06082015@5, exp 12/5/2015; 06112015@4, exp 12/8/2015; 06152015@10, exp 12/12/2015; 06162015@6, exp 12/13/2015; 06232015@12, exp 12/20/2015; 07012015@1, exp 12/28/2015; 07092015@8, exp 1/5/2016; 07132015@2, exp 1/9/2016; 07152015@10, exp 1/11/2016; 07162015@6, exp 1/12/2016; 07272015@4, exp 1/23/2016; 07282015@3, exp 1/24/2016; 07282015@4, exp 1/24/2016; 07282015@5, exp 1/24/2016; 07292015@4, exp1/25/2016; 08032015@2, exp 1/30/2016; 08032015@7, exp 1/30/2016; 08142015@10, exp 2/10/2016; 08142015@11, exp 2/10/2016; 08142015@2, exp 2/10/2016; 08142015@4, exp 2/10/2016; 08142015@6, exp 2/10/2016; 08142015@8, exp 2/10/2016; 08182015@12, exp 2/14/2016; 08182015@13, exp 2/14/2016; 08312015@4, exp 2/20/2016
Why it was recalled
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Recalling firm
- Firm
- Pacific Healthcare, Inc dba B&B Pharmacy
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 10244 Rosecrans Ave, N/A, Bellflower, California 90706-2602
Distribution
- Quantity
- 31 -10 ml vials; 16- 5 ml vials
- Distribution pattern
- CA and NJ
Timeline
- Recall initiated
- 2015-10-07
- FDA classified
- 2015-11-10
- Posted by FDA
- 2015-11-18
- Terminated
- 2016-04-07
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0169-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.